Thursday, August 27, 2026

These 13 foods Taste Much Better When Frozen

Glowing skin and healthier hair may have a lot to do with your skincare shelf and haircare routine, but what you put on your plate matters too. And no, we are not saying you need to survive on salads and green juice forever. Sometimes, all it takes is giving your daily diet a little upgrade and smoothies are one of the easiest ways to do it.

Packed with fruits, vegetables, nuts, seeds and other nutrient-rich ingredients, the right smoothie can give your body a delicious dose of vitamins, minerals, antioxidants and healthy fats. So, if you are looking to give your skin some extra glow and your hair a little more love, here are a few smoothie combinations worth adding to your routine.

1. Avocados

avocado frozen 

 The most delicious popsicles don't have to be sugary sweet, in fact, avocados make an amazingly savory alternative. What better mid-afternoon healthy snack can there be than a few frozen slices of avocado with a dash of salt and chili pepper? I can't think of one. 

2. Chocolate

Chocolate is not merely a very popular snack, it's also healthy too. Plus, the sensation of cold chocolate melting sensuously in my warm mouth is something I like to savor each and every day. When they are this cold you can really take your time, no longer wolfing down a whole pack without even appreciating the wondrousness of the chocolate. 

3. Bananas

Frozen bananas can be mashed up to make the simplest of ice-creams or milkshakes. For some reason freezing them removes that odd aftertaste that puts some people off the fruit entirely. The texture is also different when frozen, rather like a fruity popsicle.

4. Peas

Peas are one vegetable that are probably in your freezer anyway, but if you've never had a bite of a few without defrosting them first, you're missing out on the crunchiest and healthiest little snack your money can buy.

5. Grapes

 These frozen grapes are way better than any candy you can buy but quite similar in terms of the delicious sweetness. 

6. Peanut butter cups
Whether you make your own, or have always been an admirer of a certain popular brand, peanut butter cups make great frozen treats. The chocolate and peanut butter combine meltingly in your mouth to make an incredible taste sensation that is sure to get you buzzing with energy and enjoyment. 

7. Strawberries

Strawberries really benefit from being frozen, because, while their flavor remains, the extra crunchiness makes for an even more enjoyable experience. This is one you've got to try. Plus, it's great that you can keep them in the freezer instead of watching them quickly disintegrate in the fridge. 

8. Birthday cake

It's hard to believe, but some people really don't like cakes, as they seem too dry to enjoy. Well, if the cake is frozen, this objection vanishes immediately. If you haven't had frozen cake before, you are really missing a great trick.

9. Stone fruits
frozen, food,

Why do we even bother buying ice pops when we have all these great fruits at our disposable? So, whether you've managed to get your hands on some bargain, in-season peaches, pears, or whatever, pop them in the freezer for a succulent dream. As they melt, the fruits gently fill your mouth with a sweetness and juiciness that is impossible to resist. 

10. Pecans frozen, food,

The extra crunch you get from frozen pecans takes them a step above regular nuts, for some reason they also seem to taste even better too. 

11. Blueberries
frozen, food,

Blueberries are well known as delightful frozen treats. Have you tried their amazing chilled consistency yet? You'll be blown away by how refreshing they are. 

12. Mangoes
You can make some insanely delicious mango ice-cubes when you slice up the large fruit appropriately and store in the freezer.  

13. Coffee beans

 
frozen, food,

Coffee beans are renowned for their ability to really give you that great pick-me-up feeling. But, instead of having that drink, have you ever tried eating a few frozen beans? They are just like a crunchy iced-coffee! What a great idea this is!



This is only for your information, kindly take the advice of your doctor for food, medicines, exercises and so on.   


Labels: , , , , , , , , , , , , ,

FDA Approves Rasonque, New Targeted Drug That Nearly Doubled Survival In Pancreatic Cancer Trial

The US Food and Drug Administration (FDA) has approved a new targeted treatment for adults with metastatic pancreatic cancer, giving patients with one of the most difficult-to-treat forms of the disease another treatment option.

The drug, daraxonrasib, will be marketed in the US under the brand name Rasonque and was developed by Revolution Medicines. The FDA approved the once-daily oral medicine on August 26 for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.

The approval is based on results from RASolute 302, a global Phase 3 clinical trial involving 500 patients with metastatic pancreatic ductal adenocarcinoma whose disease had progressed after one previous line of systemic treatment. Patients were randomly assigned to receive either daraxonrasib or physician’s choice of standard chemotherapy.

What did the trial find?

The results showed a significant survival benefit for patients receiving daraxonrasib. In the overall trial population, the median overall survival was 13.2 months with daraxonrasib, compared with 6.7 months with standard chemotherapy. The hazard ratio for death was 0.40, meaning the relative risk of death was 60% lower in the daraxonrasib group during the study period.

The drug also improved progression-free survival. Patients receiving daraxonrasib had a median progression-free survival of 7.2 months, compared with 3.6 months among those receiving chemotherapy. The objective response rate was 30% with daraxonrasib versus 11% with chemotherapy.

The findings were published in The New England Journal of Medicine in May and later appeared in the journal’s July 2026 issue.

How does Rasonque work?

Daraxonrasib belongs to a new class of medicines designed to inhibit the RAS GTPase family, a group of proteins involved in signalling that can drive cancer-cell growth.

RAS signalling is particularly important in pancreatic ductal adenocarcinoma. According to the FDA, Rasonque targets multiple forms of RAS, a key driver of tumour growth in most pancreatic adenocarcinomas.

This makes the approval significant because it introduces a targeted treatment approach for metastatic pancreatic cancer rather than relying solely on conventional chemotherapy.

However, the drug does not cure pancreatic cancer. The FDA approval is specifically for metastatic disease in adults who meet the stated treatment criteria, and the survival figures from the trial represent median outcomes across the study population, they do not predict how long an individual patient will live.

What are the side effects?

The FDA lists several common adverse reactions associated with Rasonque, including rash, diarrhoea, stomatitis, nausea, fatigue, vomiting, abdominal pain, swelling or oedema, decreased appetite and haemorrhage. The prescribing information also includes warnings and precautions concerning dermatologic and soft-tissue toxicity, oral disorders, gastrointestinal complications, interstitial lung disease/pneumonitis and embryo-fetal toxicity.

In the RASolute 302 trial, adverse events occurred in all patients receiving daraxonrasib and in 97.7% of those receiving chemotherapy. Grade 3 or higher adverse events occurred in 61.8% of the daraxonrasib group and 69.6% of the chemotherapy group.

What makes the approval significant?

Pancreatic cancer remains challenging to treat because it is frequently diagnosed after it has already spread. The new approval does not change that reality, but it does add a targeted medicine that demonstrated a meaningful survival advantage over standard chemotherapy in a Phase 3 trial.

The FDA described the approval as a new treatment option for patients facing an “extraordinarily difficult and historically hard-to-treat cancer." The agency also said the application was reviewed under its National Priority Voucher pilot programme and that approval came 6.5 months before the user-fee deadline.

Rasonque had also been made available to some patients through an expanded-access programme before full approval. In May, the FDA issued a “safe to proceed" letter allowing Revolution Medicines to initiate the programme for eligible patients with previously treated metastatic pancreatic ductal adenocarcinoma.
 

The treatment is now available by prescription in the United States. Revolution Medicines reported a wholesale acquisition cost of $39,800 for a 30-day supply at the recommended dose.

For now, the significance of Rasonque is best understood not as a cure for pancreatic cancer, but as a new targeted treatment that substantially improved median survival compared with chemotherapy in a Phase 3 trial of previously treated metastatic disease. Further studies are also evaluating daraxonrasib in other treatment settings, including earlier lines of therapy.

 

 

This is only for your information, kindly take the advice of your doctor for food, medicines, exercises and so on.   


 

Labels: , , , , , , ,